Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Myofibroma × LFA102 monoclonal antibody × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Breast 1

Conditions

Prostatic Neoplasms 1 Myofibroma 1 Castration-resistant Prostate Cancer, Advanced Breast Cancer 1 Breast Neoplasms 1

Interventions

relugolix 2 telapristone acetate 1 estradiol, norethindrone drug combination 1 Uterine Artery Embolization 1 Tablets 1 Leuprolide 1 LFA102 monoclonal antibody 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01338831 2020-12-17

Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer

Novartis

Phase 1 Completed

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡